Eng M. Tan - Related publications

Affiliations: 
Molecular and Experimental Medicine Scripps Research Institute, La Jolla, La Jolla, CA, United States 
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2020 Wang H, Xu P, Sun G, Lv J, Cao J, Xu Z. Downregulation of PHF19 inhibits cell growth and migration in gastric cancer. Scandinavian Journal of Gastroenterology. 1-7. PMID 32449434 DOI: 10.1080/00365521.2020.1766555   
2020 Wen P, Gao Y, Chen B, Qi X, Hu G, Xu A, Xia J, Wu L, Lu H, Zhao G. Pan-Cancer Analysis of Radiotherapy Benefits and Immune Infiltration in Multiple Human Cancers. Cancers. 12. PMID 32294976 DOI: 10.3390/cancers12040957   
2020 Punnanitinont A, Kannisto ED, Matsuzaki J, Odunsi K, Yendamuri S, Singh AK, Patnaik SK. Sublethal Radiation Affects Antigen Processing and Presentation Genes to Enhance Immunogenicity of Cancer Cells. International Journal of Molecular Sciences. 21. PMID 32272797 DOI: 10.3390/ijms21072573   
2020 Jacqueline C, Finn OJ. Antibodies specific for disease-associated antigens (DAA) expressed in non-malignant diseases reveal potential new tumor-associated antigens (TAA) for immunotherapy or immunoprevention. Seminars in Immunology. 47: 101394. PMID 32273212 DOI: 10.1016/j.smim.2020.101394   
2020 Ros-Martínez S, Navas-Carrillo D, Alonso-Romero JL, Orenes-Piñero E. Immunoscore: a novel prognostic tool. Association with clinical outcome, response to treatment and survival in several malignancies. Critical Reviews in Clinical Laboratory Sciences. 1-12. PMID 32175789 DOI: 10.1080/10408363.2020.1729692   
2020 Hayashi S, Imanishi R, Adachi M, Ikejima S, Nakata J, Morimoto S, Fujiki F, Nishida S, Tsuboi A, Hosen N, Nakajima H, Hasegawa K, Oka Y, Sugiyama H, Oji Y. Reader-free ELISPOT assay for immuno-monitoring in peptide-based cancer vaccine immunotherapy. Biomedical Reports. 12: 244-250. PMID 32257187 DOI: 10.3892/br.2020.1289   
2020 Kiss I, Kolostova K, Pawlak I, Bobek V. Circulating tumor cells in gynaecological malignancies. Journal of B.U.On. : Official Journal of the Balkan Union of Oncology. 25: 40-50. PMID 32277613   
2020 Li G, Tong X, Pan L, Huang H, Ma H, Feng Y. Epididymal protein 3A is upregulated and promotes cell proliferation in non-small cell lung cancer. Oncology Letters. 19: 4024-4030. PMID 32391105 DOI: 10.3892/ol.2020.11517   
2020 Hsu ML, Naidoo J. Principles of Immunotherapy in Non-Small Cell Lung Cancer. Thoracic Surgery Clinics. 30: 187-198. PMID 32327177 DOI: 10.1016/j.thorsurg.2020.01.009   
2020 Martins F, Oliveira R, Cavadas B, Pinto F, Cardoso AP, Castro F, Sousa B, Pinto ML, Silva AJ, Adão D, Loureiro JP, Pedro N, Reis RM, Pereira L, Oliveira MJ, et al. Hypoxia and Macrophages Act in Concert Towards a Beneficial Outcome in Colon Cancer. Cancers. 12. PMID 32231135 DOI: 10.3390/cancers12040818   
2020 Yin WM, Li YW, Gu YQ, Luo M. Nanoengineered targeting strategy for cancer immunotherapy. Acta Pharmacologica Sinica. PMID 32398683 DOI: 10.1038/s41401-020-0417-3   
2020 Rajguru JP, Mouneshkumar CD, Radhakrishnan IC, Negi BS, Maya D, Hajibabaei S, Rana V. Tumor markers in oral cancer: A review. Journal of Family Medicine and Primary Care. 9: 492-496. PMID 32318370 DOI: 10.4103/jfmpc.jfmpc_1036_19   
2020 Zhang J, Xu Z, Yu B, Xu J, Yu B. Tripartite Motif Containing 35 (TRIM35) contributes to the Proliferation, Migration, and Invasion of Lung cancer cells In Vitro and Vivo. Bioscience Reports. PMID 32293015 DOI: 10.1042/BSR20200065   
2020 Guo J, Jin H, Xi Y, Guo J, Jin Y, Jiang D. The / Axis Is Involved in Regulation of Dendritic Cells and Is Associated with Clinical Outcomes in Advanced Lung Adenocarcinoma. Biomed Research International. 2020: 4360930. PMID 32258122 DOI: 10.1155/2020/4360930   
2020 Yoshida T, Ichikawa J, Giuroiu I, Laino AS, Hao Y, Krogsgaard M, Vassallo M, Woods DM, Stephen Hodi F, Weber J. C reactive protein impairs adaptive immunity in immune cells of patients with melanoma. Journal For Immunotherapy of Cancer. 8. PMID 32303612 DOI: 10.1136/jitc-2019-000234   
2020 Yang H, Jin W, Liu H, Gan D, Cui C, Han C, Wang Z. Immune-Related Prognostic Model in Colon Cancer: A Gene Expression-Based Study. Frontiers in Genetics. 11: 401. PMID 32457797 DOI: 10.3389/fgene.2020.00401   
2020 Gao L, Meng J, Zhang M, Fan S, Gao S, Wang X, Liang C. Expression and Prognostic Values of the Roof Plate-Specific Spondin Family in Bladder Cancer. Dna and Cell Biology. PMID 32352838 DOI: 10.1089/dna.2019.5224   
2020 Li W, Zeng J, Luo B, Mao Y, Liang Y, Zhao W, Hu N, Chen G, Zheng X. [High expression of activated CD4 memory T cells and CD8 T cells and low expression of M0 macrophage are associated with better clinical prognosis in bladder cancer patients]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology. 36: 97-103. PMID 32314705   
2020 Wehr J, Sikorski EL, Bloch E, Feigman MS, Ferraro NJ, Baybutt TR, Snook AE, Pires MM, Thévenin D. pH-Dependent Grafting of Cancer Cells with Antigenic Epitopes Promotes Selective Antibody-Mediated Cytotoxicity. Journal of Medicinal Chemistry. PMID 32196345 DOI: 10.1021/acs.jmedchem.0c00016   
2020 Shaaban M, Othman H, Ibrahim T, Ali M, Abdelmoaty M, Abdel-Kawi AR, Mostafa A, El Nakeeb A, Emam H, Refaat A. Immune Checkpoint Regulators: A New Era Toward Promising Cancer Therapy. Current Cancer Drug Targets. PMID 32321404 DOI: 10.2174/1568009620666200422081912   
2020 Muhammad SA, Zafar S, Rizvi SZ, Imran I, Munir F, Jamshed MB, Ali A, Wu X, Shahid N, Zaeem M, Zhang Q. Experimental Analysis of T-Cell Epitopes for Designing Liver Cancer Vaccine Predicted by System Level Immunoinformatics Approach. American Journal of Physiology. Gastrointestinal and Liver Physiology. PMID 32363891 DOI: 10.1152/ajpgi.00068.2020   
2020 Wu M, Ding J, Song J, Wang Y, Liu H. Genomic Analysis and Clinical Implications of Immune Cell Infiltration in Gastric Cancer. Bioscience Reports. PMID 32338286 DOI: 10.1042/BSR20193308   
2020 Zhang X, Quan F, Xu J, Xiao Y, Li X, Li Y. Combination of multiple tumor-infiltrating immune cells predicts clinical outcome in colon cancer. Clinical Immunology (Orlando, Fla.). 108412. PMID 32278085 DOI: 10.1016/j.clim.2020.108412   
2020 Ghafouri-Fard S, Esmaeili M, Taheri M, Samsami M. Highly upregulated in liver cancer (HULC): An update on its role in carcinogenesis. Journal of Cellular Physiology. PMID 32372477 DOI: 10.1002/jcp.29765   
2020 Ishibashi F, Sakairi Y, Iwata T, Moriya Y, Mizobuchi T, Hoshino H, Yoshida S, Hanaoka H, Yoshino I, Motohashi S. A phase I study of loco-regional immunotherapy by transbronchial injection of α-galactosylceramide-pulsed antigen presenting cells in patients with lung cancer. Clinical Immunology (Orlando, Fla.). 215: 108457. PMID 32387537 DOI: 10.1016/j.clim.2020.108457   
2020 Yadav S, Barton M, Nguyen NT. Stretching Induces Overexpression of RhoA and Rac1 GTPases in Breast Cancer Cells. Advanced Biosystems. 4: e1900222. PMID 32293133 DOI: 10.1002/adbi.201900222   
2020 Shin MH, Kim J, Lim SA, Kim J, Lee KM. Current Insights into Combination Therapies with MAPK Inhibitors and Immune Checkpoint Blockade. International Journal of Molecular Sciences. 21. PMID 32260561 DOI: 10.3390/ijms21072531   
2020 Tao R, Niu WB, Dou PH, Ni SB, Yu YP, Cai LC, Wang XY, Li SY, Zhang C, Luo ZG. Nucleobindin-2 enhances the epithelial-mesenchymal transition in renal cell carcinoma. Oncology Letters. 19: 3653-3664. PMID 32391090 DOI: 10.3892/ol.2020.11526   
2020 Stewart RL, Matynia AP, Factor RE, Varley KE. Spatially-resolved quantification of proteins in triple negative breast cancers reveals differences in the immune microenvironment associated with prognosis. Scientific Reports. 10: 6598. PMID 32313087 DOI: 10.1038/s41598-020-63539-x   
2020 Kirtonia A, Sethi G, Garg M. The multifaceted role of reactive oxygen species in tumorigenesis. Cellular and Molecular Life Sciences : Cmls. PMID 32358622 DOI: 10.1007/s00018-020-03536-5   
2020 Su D, Guo X, Huang L, Ye H, Li Z, Lin L, Chen R, Zhou Q. Tumor-neuroglia interaction promotes pancreatic cancer metastasis. Theranostics. 10: 5029-5047. PMID 32308766 DOI: 10.7150/thno.42440   
2020 Lee HO, Hong Y, Etlioglu HE, Cho YB, Pomella V, Van den Bosch B, Vanhecke J, Verbandt S, Hong H, Min JW, Kim N, Eum HH, Qian J, Boeckx B, Lambrechts D, et al. Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer. Nature Genetics. PMID 32451460 DOI: 10.1038/s41588-020-0636-z   
2020 Ren S, Ren XD, Guo LF, Qu XM, Shang MY, Dai XT, Huang Q. Urine cell-free DNA as a promising biomarker for early detection of non-small cell lung cancer. Journal of Clinical Laboratory Analysis. e23321. PMID 32281142 DOI: 10.1002/jcla.23321   
2020 Konishi H, Fujiya M, Kashima S, Sakatani A, Dokoshi T, Ando K, Ueno N, Iwama T, Moriichi K, Tanaka H, Okumura T. A tumor-specific modulation of heterogeneous ribonucleoprotein A0 promotes excessive mitosis and growth in colorectal cancer cells. Cell Death & Disease. 11: 245. PMID 32303675 DOI: 10.1038/s41419-020-2439-7   
2020 Buttacavoli M, Albanese NN, Roz E, Pucci-Minafra I, Feo S, Cancemi P. Proteomic Profiling of Colon Cancer Tissues: Discovery of New Candidate Biomarkers. International Journal of Molecular Sciences. 21. PMID 32353950 DOI: 10.3390/ijms21093096   
2020 Barr AM, Silva A, Prato S, Belz GT, Maraskovsky E, Baz Morelli A. Therapeutic ISCOMATRIX™ adjuvant vaccine elicits effective anti-tumor immunity in the TRAMP-C1 mouse model of prostate cancer. Cancer Immunology, Immunotherapy : Cii. PMID 32388678 DOI: 10.1007/s00262-020-02597-6   
2020 Hu L, Bai Z, Ma X, Bai N, Zhang Z. The Influence of Bcl-3 Expression on Cell Migration and Chemosensitivity of Gastric Cancer Cells via Regulating Hypoxia-Induced Protective Autophagy. Journal of Gastric Cancer. 20: 95-105. PMID 32269848 DOI: 10.5230/jgc.2020.20.e9   
2020 Hernandez C, Arasanz H, Chocarro L, Bocanegra A, Zuazo M, Fernandez-Hinojal G, Blanco E, Vera R, Escors D, Kochan G. Systemic Blood Immune Cell Populations as Biomarkers for the Outcome of Immune Checkpoint Inhibitor Therapies. International Journal of Molecular Sciences. 21. PMID 32244396 DOI: 10.3390/ijms21072411   
2020 Pawlak A, Henklewska M. The Role of Bcl-xL Protein Research in Veterinary Oncology. International Journal of Molecular Sciences. 21. PMID 32260403 DOI: 10.3390/ijms21072511   
2020 Kim N, Kim HK, Lee K, Hong Y, Cho JH, Choi JW, Lee JI, Suh YL, Ku BM, Eum HH, Choi S, Choi YL, Joung JG, Park WY, Jung HA, et al. Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma. Nature Communications. 11: 2285. PMID 32385277 DOI: 10.1038/s41467-020-16164-1   
2020 Dianat-Moghadam H, Azizi M, Eslami-S Z, Cortés-Hernández LE, Heidarifard M, Nouri M, Alix-Panabières C. The Role of Circulating Tumor Cells in the Metastatic Cascade: Biology, Technical Challenges, and Clinical Relevance. Cancers. 12. PMID 32260071 DOI: 10.3390/cancers12040867   
2020 Wang W, Bai L, Xu D, Li W, Cui J. Immunotherapy: A Potential Approach to Targeting Cancer Stem Cells. Current Cancer Drug Targets. PMID 32364076 DOI: 10.2174/1568009620666200504111914   
2020 Ma L, He H, Jiang K, Jiang P, He H, Feng S, Chen K, Shao J, Deng G. FAM46C inhibits cell proliferation and cell cycle progression and promotes apoptosis through PTEN/AKT signaling pathway and is associated with chemosensitivity in prostate cancer. Aging. 12. PMID 32283544 DOI: 10.18632/aging.103030   
2020 Shi T, Song X, Wang Y, Liu F, Wei J. Combining Oncolytic Viruses With Cancer Immunotherapy: Establishing a New Generation of Cancer Treatment. Frontiers in Immunology. 11: 683. PMID 32411132 DOI: 10.3389/fimmu.2020.00683   
2020 Safari F, Bayat M, Nasri S, Karami S. Synthesis and evaluation of anti-tumor activity of novel triazolo[1,5-a] pyrimidine on cancer cells by induction of cellular apoptosis and inhibition of epithelial-to-mesenchymal transition process. Bioorganic & Medicinal Chemistry Letters. 127111. PMID 32199733 DOI: 10.1016/j.bmcl.2020.127111   
2020 Minnix M, Li L, Yazaki P, Chea J, Poku E, Colcher D, Shively JE. Improved targeting of an anti-TAG-72 antibody drug conjugate for the treatment of ovarian cancer. Cancer Medicine. PMID 32368864 DOI: 10.1002/cam4.3078   
2020 Liang J, Chen D, Chen L, She X, Zhang H, Xiao Y. The potentiality of immunotherapy for sarcomas: a summary of potential predictive biomarkers. Future Oncology (London, England). PMID 32396026 DOI: 10.2217/fon-2020-0118   
2020 McGoverne I, Dunn J, Batham J, Tu WJ, Chrisp J, Rao S. Epitherapy and immune checkpoint blockade: using epigenetic reinvigoration of exhausted and dysfunctional T cells to reimburse immunotherapy response. Bmc Immunology. 21: 22. PMID 32316916 DOI: 10.1186/s12865-020-00353-0   
2020 Shen C, Liu J, Wang J, Yang X, Niu H, Wang Y. The Analysis of PTPN6 for Bladder Cancer: An Exploratory Study Based on TCGA. Disease Markers. 2020: 4312629. PMID 32454905 DOI: 10.1155/2020/4312629   
2020 Yu F, Lin Y, Xu X, Liu W, Tang D, Zhou X, Wang G, Zheng Y, Xie A. Knockdown of GSG2 inhibits prostate cancer progression in vitro and in vivo. International Journal of Oncology. PMID 32319597 DOI: 10.3892/ijo.2020.5043